BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 25762787)

  • 1. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.
    Walter ND; Dolganov GM; Garcia BJ; Worodria W; Andama A; Musisi E; Ayakaka I; Van TT; Voskuil MI; de Jong BC; Davidson RM; Fingerlin TE; Kechris K; Palmer C; Nahid P; Daley CL; Geraci M; Huang L; Cattamanchi A; Strong M; Schoolnik GK; Davis JL
    J Infect Dis; 2015 Sep; 212(6):990-8. PubMed ID: 25762787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.
    Honeyborne I; McHugh TD; Kuittinen I; Cichonska A; Evangelopoulos D; Ronacher K; van Helden PD; Gillespie SH; Fernandez-Reyes D; Walzl G; Rousu J; Butcher PD; Waddell SJ
    BMC Med; 2016 Apr; 14():68. PubMed ID: 27055815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
    Desjardin LE; Perkins MD; Wolski K; Haun S; Teixeira L; Chen Y; Johnson JL; Ellner JJ; Dietze R; Bates J; Cave MD; Eisenach KD
    Am J Respir Crit Care Med; 1999 Jul; 160(1):203-10. PubMed ID: 10390401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
    Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum is a surrogate for bronchoalveolar lavage for monitoring Mycobacterium tuberculosis transcriptional profiles in TB patients.
    Garcia BJ; Loxton AG; Dolganov GM; Van TT; Davis JL; de Jong BC; Voskuil MI; Leach SM; Schoolnik GK; Walzl G; Strong M; Walter ND
    Tuberculosis (Edinb); 2016 Sep; 100():89-94. PubMed ID: 27553415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.
    Walter ND; Moore CM; Kayigire XA; Dide-Agossou C; Worodria W; Huang L; Everett CK; Schoolnik GS; Nahid P; Davis JL
    BMC Infect Dis; 2018 Jul; 18(1):293. PubMed ID: 29970012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
    Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
    BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.
    Tudó G; Laing K; Mitchison DA; Butcher PD; Waddell SJ
    Future Med Chem; 2010 Aug; 2(8):1371-83. PubMed ID: 21426023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB.
    Barr DA; Kamdolozi M; Nishihara Y; Ndhlovu V; Khonga M; Davies GR; Sloan DJ
    Tuberculosis (Edinb); 2016 May; 98():110-5. PubMed ID: 27156626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments.
    Kayigire XA; Friedrich SO; van der Merwe L; Donald PR; Diacon AH
    Tuberculosis (Edinb); 2015 Dec; 95(6):770-779. PubMed ID: 26318558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients.
    Walter ND; de Jong BC; Garcia BJ; Dolganov GM; Worodria W; Byanyima P; Musisi E; Huang L; Chan ED; Van TT; Antonio M; Ayorinde A; Kato-Maeda M; Nahid P; Leung AM; Yen A; Fingerlin TE; Kechris K; Strong M; Voskuil MI; Davis JL; Schoolnik GK
    J Infect Dis; 2016 Oct; 214(8):1205-11. PubMed ID: 27534685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Profiling Mycobacterium tuberculosis from Patient Sputa.
    Wildner LM; Gould KA; Waddell SJ
    Methods Mol Biol; 2018; 1736():117-128. PubMed ID: 29322464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of messenger RNA (mRNA) of Mycobacterium tuberculosis as a marker of cure in patients with pulmonary tuberculosis.
    Montenegro RA; Guarines KM; Montenegro LM; Lira LA; Falcão J; Melo FL; Santos FC; Nascimento AL; Zuzarte MS; Leite RC; Schindler HC
    J Appl Microbiol; 2014 Jul; 117(1):266-72. PubMed ID: 24684542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive gene profiling of Mycobacterium tuberculosis during sub-lethal kanamycin exposure.
    Habib Z; Xu W; Jamal M; Rehman K; Dai J; Fu ZF; Chen X; Cao G
    Microb Pathog; 2017 Nov; 112():243-253. PubMed ID: 28966063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients.
    Abbadi S; El Hadidy G; Gomaa N; Cooksey R
    Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum.
    Mdivani N; Li H; Akhalaia M; Gegia M; Goginashvili L; Kernodle DS; Khechinashvili G; Tang YW
    Clin Chem; 2009 Sep; 55(9):1694-700. PubMed ID: 19574468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host blood RNA signatures predict the outcome of tuberculosis treatment.
    Thompson EG; Du Y; Malherbe ST; Shankar S; Braun J; Valvo J; Ronacher K; Tromp G; Tabb DL; Alland D; Shenai S; Via LE; Warwick J; Aderem A; Scriba TJ; Winter J; Walzl G; Zak DE;
    Tuberculosis (Edinb); 2017 Dec; 107():48-58. PubMed ID: 29050771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.